ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1111

$1.78M Total Retail Price of All Prescriptions

Rank: 7 out of 1111

618 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 12,854 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 699 376 1 4
LEVOTHYROXINE SODIUM 525 344 2 3
FUROSEMIDE 507 359 3 6
TRAMADOL HCL 493 307 4 13
SIMVASTATIN 484 268 5 5
LISINOPRIL 451 317 6 2
GABAPENTIN 409 238 7 10
CITALOPRAM HBR 390 249 8 14
DICLOFENAC SODIUM 337 141 9 108
BACLOFEN 302 107 10 119
CRESTOR 294 154 11 33
AMLODIPINE BESYLATE 282 238 12 7
CYMBALTA 278 121 13 40
NAMENDA 273 240 14 31
POTASSIUM CHLORIDE 266 170 15 9
METFORMIN HCL ER 254 148 16 84
NEXIUM 248 122 17 26
WARFARIN SODIUM 241 173 18 19
CLOPIDOGREL 220 167 19 30
CEFUROXIME 215 135 20 138
PRAVASTATIN SODIUM 215 155 20 17
RANITIDINE HCL 211 121 22 29
ATORVASTATIN CALCIUM 196 157 23 15
PROAIR HFA 186 99 24 38
ATENOLOL 182 119 25 22
PLAVIX 172 121 26 49
METFORMIN HCL 170 104 27 8
ABILIFY 168 47 28 123
HYDROCHLOROTHIAZIDE 163 118 29 11
FLUTICASONE PROPIONATE 162 71 30 27
DOXAZOSIN MESYLATE 162 99 30 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 158 99 32 71
FLUOXETINE HCL 155 74 33 44
MELOXICAM 149 79 34 18
PREDNISONE 136 82 35 48
CELEBREX 134 108 36 81
DIOVAN 132 81 37 51
ALLOPURINOL 128 92 38 36
DIGOXIN 127 92 39 47
MOMETASONE FUROATE 126 71 40 344
METOPROLOL TARTRATE 125 90 41 12
PROMETHAZINE HCL 123 25 R 42 69
ADVAIR DISKUS 122 37 43 43
SPIRIVA 118 77 44 53
EXELON 116 102 45 121
ACTOS 115 96 46 98
MECLIZINE HCL 115 85 46 162
TOPIRAMATE 115 35 46 177
OLANZAPINE 115 113 46 117
ROPINIROLE HCL 110 74 50 68
JANUVIA 109 38 51 75
DOXYCYCLINE HYCLATE 108 59 52 113
CARVEDILOL 103 95 53 21
HYDROXYZINE HCL 103 48 R 53 159
METOCLOPRAMIDE HCL 101 63 55 130
LEVETIRACETAM 100 51 56 111
BUSPIRONE HCL 100 26 56 96
SULINDAC 100 33 56 217
LOSARTAN POTASSIUM 99 74 59 34
TRAZODONE HCL 99 63 59 32
VENLAFAXINE HCL ER 99 57 59 105
ENALAPRIL MALEATE 97 75 62 56
LACTULOSE 97 21 62 166
RAMIPRIL 97 56 62 168
ESCITALOPRAM OXALATE 95 85 65 78
RISPERIDONE 94 12 66 60
IBUPROFEN 93 40 67 66
TERAZOSIN HCL 92 70 68 127
PANTOPRAZOLE SODIUM 91 64 69 50
SERTRALINE HCL 90 42 70 24
BENAZEPRIL HCL 90 57 70 97
CARBIDOPA-LEVODOPA 90 87 70 101
SYMBICORT 90 69 70 176
METOPROLOL SUCCINATE 86 63 74 20
VESICARE 86 52 74 244
AZITHROMYCIN 85 58 76 39
PREMARIN 84 26 R 77 90
NAPROXEN 83 45 78 85
QUINAPRIL HCL 81 49 79 213
MIRTAZAPINE 79 47 80 52
DOXEPIN HCL 77 32 81 215
CEPHALEXIN 76 52 82 89
POLYETHYLENE GLYCOL 3350 75 36 83 45
FINASTERIDE 74 67 84 115
GLIPIZIDE ER 73 51 85 99
DONEPEZIL HCL 72 60 86 25
ALENDRONATE SODIUM 72 62 86 35
PRAMIPEXOLE DIHYDROCHLORIDE 72 47 86 186
OXYBUTYNIN CHLORIDE ER 72 59 86 114
DALIRESP 70 49 90 375
FAMOTIDINE 69 46 91 77
TRILIPIX 69 37 91 197
CYCLOBENZAPRINE HCL 68 19 R 93 37
FLUCONAZOLE 68 35 93 195
AGGRENOX 67 46 95 182
TIZANIDINE HCL 66 19 96 91
BUPROPION HCL SR 66 15 96 150
SINGULAIR 66 45 96 112
VENTOLIN HFA 65 32 99 122
TAMSULOSIN HCL 64 57 100 28
KLOR-CON M20 64 61 100 79
ALBUTEROL SULFATE 63 51 102 136
PIOGLITAZONE HCL 62 49 R 103 269
COMBIVENT 61 20 104 129
VENLAFAXINE HCL 61 34 104 191
GLIPIZIDE 60 35 106 57
HYDROXYZINE PAMOATE 60 21 R 106 205
PEN NEEDLE 59 28 108 207
NITROFURANTOIN MONO-MACRO 59 26 108 149
ISOSORBIDE MONONITRATE ER 58 58 110 73
SEROQUEL XR 57 16 111 237
METHOTREXATE 54 40 112 284
BYSTOLIC 53 40 113 133
DETROL LA 52 21 114 139
NOVOLOG 52 23 114 104
QUETIAPINE FUMARATE 51 14 116 76
BYETTA 51 27 116 416
DIOVAN HCT 50 43 118 94
LEVEMIR 50 38 118 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.